Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jia Wei Jing Xie Yin is a traditional Chinese herbal medicine formula, originally derived from the classic prescription "Jing Xie Yin" created by TCM doctor Wu Jun. It is primarily used for the treatment of psoriasis, especially the blood-heat type. Clinical and preclinical studies have demonstrated that Jia Wei Jing Xie Yin exerts significant anti-psoriatic effects by modulating immune responses. Its mechanism of action involves inhibition of Th17 cell responses and downregulation of related cytokines such as interleukin-17A (IL-17A), IL-17F, IL-1β, interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α). The formula also regulates gamma delta T cells and suppresses the interleukin-23/T-helper 17 immune inflammation axis. There is no significant effect on Th1 or regulatory T cells (Treg). The preparation consists of multiple herbal ingredients processed according to traditional decoction methods[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jia Wei Jing Xie Yin.